Indianapolis-based Eli Lilly and Company is investing in a $250 million Australian capital venture fund, reports Inside INdiana Business. The fund will be designed to support development of Australia's biotechnology industry.
.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment